Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Dezima Pharma begins phase IIb TULIP trial for DEZ-001

Aug. 30, 2013

Isis Pharmaceuticals begins phase II diabetes study

Aug. 30, 2013

The identification of an accessory protein that plays a role in mammalian obesity

Aug. 30, 2013

Japanese launch for Bonviva injection

Aug. 29, 2013

Orexigen receives DMC clearance to conduct interim analysis for the Light Study

Aug. 28, 2013

New cathepsin S and/or L inhibitors synthesized at Roche

Aug. 28, 2013

Ultragenyx Pharmaceutical's triheptanoin IND is now active

Aug. 27, 2013

New FSH-R agonists discovered by Merck KGaA

Aug. 27, 2013

Eolas Therapeutics divulges novel OX1/OX2 receptor antagonists

Aug. 26, 2013

Korean researchers disclose new DGAT1 inhibitors

Aug. 26, 2013

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...